ArticleBMC gastroenterology2022
Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma.
Xiaoying Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it